This indicates that the primary distinction between the tumor brain barrier and the normal blood–brain barrier lies in its structural abnormalities, particularly increased fenestration, which is commonly driven by the overexpression of vascular endothelial growth factor (VEGF). Here, VEGFA is linked to neoplasm.